ascididemin has been researched along with cleistopholine in 2 studies
| Studies (ascididemin) | Trials (ascididemin) | Recent Studies (post-2010) (ascididemin) | Studies (cleistopholine) | Trials (cleistopholine) | Recent Studies (post-2010) (cleistopholine) |
|---|---|---|---|---|---|
| 23 | 0 | 10 | 11 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappoen, D; Claes, P; De Kimpe, N; Huygen, K; Jacobs, J; Mathys, V; Mbala, BM; Mertens, B; Verschaeve, L | 1 |
| Hussain, T; Pati, S; Swain, SS | 1 |
2 other study(ies) available for ascididemin and cleistopholine
| Article | Year |
|---|---|
Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholine.
Topics: Alkaloids; Anthraquinones; Anti-Bacterial Agents; Aza Compounds; Biological Products; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Naphthyridines; Structure-Activity Relationship | 2013 |
Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |